Business
STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year
Full year fiscal 2026 revenue from continuing operations increased 9%; constant currency organic revenue growth was 7% Full year fiscal 2026 as reported diluted EPS from continuing operations increased to $7.93; adjusted EPS per diluted share increased to $10.17Board approves new $1 billion share repurchase program DUBLIN, IRELAND, May 11, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 fourth quarter and full year
About this update from Steris Plc (ireland)
[{"type":"image","alt":"STERIS plc","displaySize":"","headline":null,"caption":"STERIS plc","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":49,"url":"https://media.zenfs.com/en/globenewswire.com/61c0b036d78c693a74a778c5841207dc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/yoTbl5psJ9bcVT4E7W8NWg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTY5/https://media.zenfs.com/en/globenewswire.com/61c0b036d78c693a74a778c5841207dc","width":300,"height":49},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/yoTbl5psJ9bcVT4E7W8NWg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTY5/https://media.zenfs.com/en/globenewswire.com/61c0b036d78c693a74a778c5841207dc","width":300,"height":49}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Full year fiscal 2026 revenue from continuing operations increased 9%; constant currency organic revenue growth was 7% ","length":118,"tagName":"p"}]},{"val":[{"type":"text","content":"Full year fiscal 2026 as reported diluted EPS from continuing operations increased to $7.93; adjusted EPS per diluted share increased to $10.17","length":143,"tagName":"p"}]},{"val":[{"type":"text","content":"Board approves new $1 billion share repurchase program","length":54,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":315,"olType":false},{"type":"text","content":"DUBLIN, IRELAND, May 11, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 fourth quarter and full year ended March 31, 2026. Total revenue from continuing operations for the fourth quarter of fiscal 2026 increased 7% to $1.6 billion compared with $1.5 billion in the fourth quarter of fiscal 2025. Constant currency organic revenue growth from continuing operations grew 5% in the fourth quarter.","length":477,"tagName":"p"},{"type":"text","content":"Revenue from continuing operations for the full year fiscal 2026 increased 9% to $5.9 billion compared with $5.5 billion in fiscal 2025. Constant currency organic revenue growth from continuing operations grew 7% for fiscal 2026.","length":229,"tagName":"p"},{"type":"text","content":"“Fiscal 2026 was another record year,” said Dan Carestio, President and CEO of STERIS. “Our diversified Customer base and growth in procedure volumes continue to drive our performance. We appreciate the efforts of our global Associa...